Skip to content

Treatment of Adult Men with Metastatic Castration-resistant Prostate Cancer Who Are Asymptomatic or Mildly Symptomatic After Failure of Androgen Deprivation Therapy in Whom Chemotherapy Is Not Yet Clinically Indicated

Treatment of Adult Men with Metastatic Castration-resistant Prostate Cancer Who Are Asymptomatic or Mildly Symptomatic After Failure of Androgen Deprivation Therapy in Whom Chemotherapy Is Not Yet Clinically Indicated is a serious health matter that can affect many aspects of life. The medicines listed here including Enzalutamide represent options that a clinician may discuss. Products containing Enzalutamide feature in this group.

Xtandi

Enzalutamide

40mg

Blocks androgen receptors and inhibits androgen receptor signalling to slow prostate cancer growth and delay disease progression in adult men with prostate cancer.

From$19.02/ capsuleView

Review product labelling and speak with a healthcare professional before treatment decisions.